Australia markets closed

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
25.29-0.41 (-1.60%)
At close: 03:00PM CST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
864,059
829,072
767,137
636,051
Cost of revenue
147,249
129,207
126,373
105,672
Gross profit
716,810
699,864
640,765
530,379
Operating expenses
Research development
49,731
47,824
50,825
48,485
Selling general and administrative
361,418
356,565
355,429
309,012
Total operating expenses
442,121
432,505
440,809
374,181
Operating income or loss
274,689
267,359
199,956
156,198
Interest expense
31,980
13,028
10,170
11,716
Income before tax
287,007
277,966
201,061
153,702
Income tax expense
272.9928
452.5683
749.2865
1,990
Income from continuing operations
286,734
277,513
200,311
151,712
Net income
287,008
277,783
200,827
151,712
Net income available to common shareholders
287,008
277,783
200,827
151,712
Basic EPS
1.47
1.43
1.05
0.82
Diluted EPS
1.47
1.43
1.05
0.82
Basic average shares
195,791
194,254
191,263
184,323
Diluted average shares
195,791
194,254
191,263
184,323